169 related articles for article (PubMed ID: 38369721)
1. Phenothiazines: Nrf2 activation and antioxidant effects.
Egbujor MC; Tucci P; Buttari B; Nwobodo DC; Marini P; Saso L
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23661. PubMed ID: 38369721
[TBL] [Abstract][Full Text] [Related]
2. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
[TBL] [Abstract][Full Text] [Related]
4. An insight into role of amino acids as antioxidants via NRF2 activation.
Egbujor MC; Olaniyan OT; Emeruwa CN; Saha S; Saso L; Tucci P
Amino Acids; 2024 Mar; 56(1):23. PubMed ID: 38506925
[TBL] [Abstract][Full Text] [Related]
5. Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells.
Liang F; Cao W; Huang Y; Fang Y; Cheng Y; Pan S; Xu X
Biofactors; 2019 Jul; 45(4):563-574. PubMed ID: 31131946
[TBL] [Abstract][Full Text] [Related]
6. Possible activation of NRF2 by Vitamin E/Curcumin against altered thyroid hormone induced oxidative stress via NFĸB/AKT/mTOR/KEAP1 signalling in rat heart.
Mishra P; Paital B; Jena S; Swain SS; Kumar S; Yadav MK; Chainy GBN; Samanta L
Sci Rep; 2019 May; 9(1):7408. PubMed ID: 31092832
[TBL] [Abstract][Full Text] [Related]
7. Role of oxidative stress in pathophysiology of rheumatoid arthritis: insights into NRF2-KEAP1 signalling.
Kaur G; Sharma A; Bhatnagar A
Autoimmunity; 2021 Nov; 54(7):385-397. PubMed ID: 34415206
[TBL] [Abstract][Full Text] [Related]
8. Activation of kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2/antioxidant response element pathway by curcumin enhances the anti-oxidative capacity of corneal endothelial cells.
Guo SP; Chang HC; Lu LS; Liu DZ; Wang TJ
Biomed Pharmacother; 2021 Sep; 141():111834. PubMed ID: 34153850
[TBL] [Abstract][Full Text] [Related]
9. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection.
Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F
J Virol; 2020 May; 94(10):. PubMed ID: 32161178
[TBL] [Abstract][Full Text] [Related]
10. An Overview of NRF2-Activating Compounds Bearing α,β-Unsaturated Moiety and Their Antioxidant Effects.
Egbujor MC; Buttari B; Profumo E; Telkoparan-Akillilar P; Saso L
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955599
[TBL] [Abstract][Full Text] [Related]
11.
Hu X; Mu L; Zhu L; Chang X; Nie L; Wang L; Li G
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278476
[TBL] [Abstract][Full Text] [Related]
12. Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review.
Singh E; Matada GSP; Abbas N; Dhiwar PS; Ghara A; Das A
Inflammopharmacology; 2021 Oct; 29(5):1347-1355. PubMed ID: 34373972
[TBL] [Abstract][Full Text] [Related]
13. The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease.
Geertsema S; Bourgonje AR; Fagundes RR; Gacesa R; Weersma RK; van Goor H; Mann GE; Dijkstra G; Faber KN
Trends Mol Med; 2023 Oct; 29(10):830-842. PubMed ID: 37558549
[TBL] [Abstract][Full Text] [Related]
14. Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway.
Richardson BG; Jain AD; Speltz TE; Moore TW
Bioorg Med Chem Lett; 2015 Jun; 25(11):2261-8. PubMed ID: 25937010
[TBL] [Abstract][Full Text] [Related]
15. Ginnalin A Binds to the Subpockets of Keap1 Kelch Domain To Activate the Nrf2-Regulated Antioxidant Defense System in SH-SY5Y Cells.
Zhang Z; Peng L; Fu Y; Wang W; Wang P; Zhou F
ACS Chem Neurosci; 2021 Mar; 12(5):872-882. PubMed ID: 33571414
[TBL] [Abstract][Full Text] [Related]
16. The role of Nrf2 and PPARgamma in the improvement of oxidative stress in hypertension and cardiovascular diseases.
Dovinova I; Kvandová M; Balis P; Gresova L; Majzunova M; Horakova L; Chan JY; Barancik M
Physiol Res; 2020 Dec; 69(Suppl 4):S541-S553. PubMed ID: 33656904
[TBL] [Abstract][Full Text] [Related]
17. Activation of Nrf2 pathway as a protective mechanism against oxidative stress-induced diseases: Potential of astaxanthin.
Kanwugu ON; Glukhareva TV
Arch Biochem Biophys; 2023 Jun; 741():109601. PubMed ID: 37086962
[TBL] [Abstract][Full Text] [Related]
18. Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway.
Liu S; Pi J; Zhang Q
Redox Biol; 2022 Aug; 54():102389. PubMed ID: 35792437
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2.
Alam MM; Okazaki K; Nguyen LTT; Ota N; Kitamura H; Murakami S; Shima H; Igarashi K; Sekine H; Motohashi H
J Biol Chem; 2017 May; 292(18):7519-7530. PubMed ID: 28314773
[TBL] [Abstract][Full Text] [Related]
20. The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Lu MC; Ji JA; Jiang ZY; You QD
Med Res Rev; 2016 Sep; 36(5):924-63. PubMed ID: 27192495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
